gelmann edward (15 risultati)

Hardcover. Condizione: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.

Condizione: New.

Condizione: New. In.

Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been discovered that are critical drivers of large cross-sections of human cancers. These discoveries have allowed us to find drugs that target these drivers and make important strides in treatment. Genomics and high-throughput technologies have illuminated the complexity of cancer and the facility with which cancers adapt during their natural history. The field is evolving rapidly with new discoveries and new drugs reported monthly. This book is a timely foundation for understanding in context the origins of molecular oncology and its future directions. The content reviews available technologies for the analysis of cancer tissues and genes; summaries of key oncogenic pathways from a molecular perspective; the technologies, pathways and targeted therapies of a wide range of human malignancies; and new pharmacologic therapies that have a common mechanistic target.

Hardcover. Condizione: Brand New. 1st edition. 961 pages. 12.00x10.00x2.00 inches. In Stock.

Condizione: New. Reviews the origins of molecular oncology, including technologies for cancer analysis, key pathways in human malignancies, and available pharmacologic therapies. Editor(s): Gelman, Edward P.; Sawyers, Charles L.; Rauscher, Frank J. Num Pages: 979 pages, 48 b/w illus. 317 colour illus. 91 tables. BIC Classification: MJCL. Category: (U) Tertiary Education (US: College). Dimension: 279 x 225 x 44. Weight in Grams: 2966. . 2014. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.

Condizione: New. Reviews the origins of molecular oncology, including technologies for cancer analysis, key pathways in human malignancies, and available pharmacologic therapies. Editor(s): Gelman, Edward P.; Sawyers, Charles L.; Rauscher, Frank J. Num Pages: 979 pages, 48 b/w illus. 317 colour illus. 91 tables. BIC Classification: MJCL. Category: (U) Tertiary Education (US: College). Dimension: 279 x 225 x 44. Weight in Grams: 2966. . 2014. 1st Edition. Hardcover. . . . .

Hardcover. Condizione: new. Hardcover. The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been discovered that are critical drivers of large cross-sections of human cancers. These discoveries have allowed us to find drugs that target these drivers and make important strides in treatment. Genomics and high-throughput technologies have illuminated the complexity of cancer and the facility with which cancers adapt during their natural history. The field is evolving rapidly with new discoveries and new drugs reported monthly. This book is a timely foundation for understanding in context the origins of molecular oncology and its future directions. The content reviews available technologies for the analysis of cancer tissues and genes; summaries of key oncogenic pathways from a molecular perspective; the technologies, pathways and targeted therapies of a wide range of human malignancies; and new pharmacologic therapies that have a common mechanistic target. The genomic era has greatly facilitated the understanding of the molecular changes that underlie malignant transformation. This timely foundation for understanding the origins of molecular oncology reviews available technologies for cancer analysis, summaries of key oncogenic pathways for a wide range of human malignancies, and pharmacologic therapies in development. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condizione: New. Print on Demand pp. 796.

Hardcover. Condizione: Brand New. 1st edition. 961 pages. 12.00x10.00x2.00 inches. In Stock. This item is printed on demand.

Condizione: New. Print on Demand pp. 796 365 Illus. (317 Col.).

Condizione: New. PRINT ON DEMAND pp. 796.

Hardcover. Condizione: new. Hardcover. The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been discovered that are critical drivers of large cross-sections of human cancers. These discoveries have allowed us to find drugs that target these drivers and make important strides in treatment. Genomics and high-throughput technologies have illuminated the complexity of cancer and the facility with which cancers adapt during their natural history. The field is evolving rapidly with new discoveries and new drugs reported monthly. This book is a timely foundation for understanding in context the origins of molecular oncology and its future directions. The content reviews available technologies for the analysis of cancer tissues and genes; summaries of key oncogenic pathways from a molecular perspective; the technologies, pathways and targeted therapies of a wide range of human malignancies; and new pharmacologic therapies that have a common mechanistic target. The genomic era has greatly facilitated the understanding of the molecular changes that underlie malignant transformation. This timely foundation for understanding the origins of molecular oncology reviews available technologies for cancer analysis, summaries of key oncogenic pathways for a wide range of human malignancies, and pharmacologic therapies in development. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The genomic era has greatly facilitated the understanding of the molecular changes that underlie malignant transformation. This timely foundation for understanding the origins of molecular oncology reviews available technologies for cancer analysis, summari.

Hardcover. Condizione: new. Hardcover. The genomic era has allowed enormous strides in our understanding of the molecular changes that underlie malignant transformation. Mutations have been discovered that are critical drivers of large cross-sections of human cancers. These discoveries have allowed us to find drugs that target these drivers and make important strides in treatment. Genomics and high-throughput technologies have illuminated the complexity of cancer and the facility with which cancers adapt during their natural history. The field is evolving rapidly with new discoveries and new drugs reported monthly. This book is a timely foundation for understanding in context the origins of molecular oncology and its future directions. The content reviews available technologies for the analysis of cancer tissues and genes; summaries of key oncogenic pathways from a molecular perspective; the technologies, pathways and targeted therapies of a wide range of human malignancies; and new pharmacologic therapies that have a common mechanistic target. The genomic era has greatly facilitated the understanding of the molecular changes that underlie malignant transformation. This timely foundation for understanding the origins of molecular oncology reviews available technologies for cancer analysis, summaries of key oncogenic pathways for a wide range of human malignancies, and pharmacologic therapies in development. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.